Kindlin-1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types

Clin Transl Med. 2022 Apr;12(4):e813. doi: 10.1002/ctm2.813.

¹ Pharmacogenomics Unit, Genetics Department, Institut Curie, Paris, France.
² Department of Medical Oncology, Institut Curie, Paris, France.
³ Translational Research, Institut Curie, PSL Research University, Paris, France.
⁴ Pathology Department, Institut Curie, Paris, France.
⁵ Pathology Department, Foch Hospital, Suresnes, France.
⁶ Department of Drug Development and Innovation (D3i), Institut Curie, Paris-Saclay University, Paris & Saint Cloud, France.

No abstract available

Publication types